Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Relaxin 1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA544603
Description
Peptide sequence: EIVPSFINKD TETIIIMLEF IANLPPELKA ALSERQPSLP ELQQYVPALK Sequence homology: Human: 100%; Pig: 92%; Rat: 79%.
Relaxins are known endocrine and autocrine/paracrine hormones, belonging to the insulin gene superfamily. In the human there are three non-allelic relaxin genes, RLN1, RLN2 and RLN3. RLN1 and RLN2 share high sequence homology. This encoded protein is synthesized as a single-chain polypeptide but the active form consists of an A chain and a B chain linked by disulfide bonds; however, their exact cleavage sites have not been described. Relaxin is produced by the ovary, and targets the mammalian reproductive system to ripen the cervix, elongate the pubic symphysis and inhibit uterine contraction. It may have additional roles in enhancing sperm motility, regulating blood pressure, controlling heart rate and releasing oxytocin and vasopressin. This gene has multiple polyadenylation sites. There are multiple alternatively spliced transcript variants described for this gene but their full length nature is not known yet.
Specifications
Relaxin 1 | |
Polyclonal | |
Unconjugated | |
Rln1 | |
bA12D24.3.1; bA12D24.3.2; H1; H1RLX; preprorelaxin; preprorelaxin H1; prorelaxin 1; Prorelaxin H1; RELAX; relaxin 1; Relaxin 1 (H1); Relaxin A chain; Relaxin B chain; relaxin RLXH1; Rln; Rln1; rlx; RLX bA12D24.3.1; RLXH1 | |
Rabbit | |
Affinity chromatography | |
RUO | |
6013 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Western Blot | |
0.5 mg/mL | |
PBS with 2% sucrose and 0.09% sodium azide | |
P04808 | |
Rln1 | |
Synthetic peptide directed towards the middle region of human RLN1. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction